These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 33771846)

  • 1. Cost-Effectiveness of Offering Cervical Cancer Screening with HPV Self-Sampling among African-American Women in the Mississippi Delta.
    Campos NG; Scarinci IC; Tucker L; Peral S; Li Y; Regan MC; Sy S; Castle PE; Kim JJ
    Cancer Epidemiol Biomarkers Prev; 2021 Jun; 30(6):1114-1121. PubMed ID: 33771846
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cost-effectiveness of HPV-based cervical cancer screening in the public health system in Nicaragua.
    Campos NG; Mvundura M; Jeronimo J; Holme F; Vodicka E; Kim JJ
    BMJ Open; 2017 Jun; 7(6):e015048. PubMed ID: 28619772
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cost-effectiveness evaluation of HPV self-testing offered to non-attendees in cervical cancer screening in Switzerland.
    Vassilakos P; Poncet A; Catarino R; Viviano M; Petignat P; Combescure C
    Gynecol Oncol; 2019 Apr; 153(1):92-99. PubMed ID: 30718124
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cost-effectiveness analysis of repeated self-sampling for HPV testing in primary cervical screening: a randomized study.
    Aarnio R; Östensson E; Olovsson M; Gustavsson I; Gyllensten U
    BMC Cancer; 2020 Jul; 20(1):645. PubMed ID: 32660432
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acceptability and usability of self-collected sampling for HPV testing among African-American women living in the Mississippi Delta.
    Scarinci IC; Litton AG; Garcés-Palacio IC; Partridge EE; Castle PE
    Womens Health Issues; 2013; 23(2):e123-30. PubMed ID: 23410619
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Given a choice between self-sampling at home for HPV testing and standard of care screening at the clinic, what do African American women choose? Findings from a group randomized controlled trial.
    Scarinci IC; Li Y; Tucker L; Campos NG; Kim JJ; Peral S; Castle PE
    Prev Med; 2021 Jan; 142():106358. PubMed ID: 33338505
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Optimal Management Strategies for Primary HPV Testing for Cervical Screening: Cost-Effectiveness Evaluation for the National Cervical Screening Program in Australia.
    Simms KT; Hall M; Smith MA; Lew JB; Hughes S; Yuill S; Hammond I; Saville M; Canfell K
    PLoS One; 2017; 12(1):e0163509. PubMed ID: 28095411
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Results and cost evaluation of triage with high risk HPV test in cervical cancer screening. A pilot study in Piedmont (North-West Italy)].
    Magnani C; Gillio Tos A; De Marco L; Calvia M; Cipelletti A; Bestagini P; Pagano E; Segnan N; Ronco G
    Epidemiol Prev; 2012; 36(2):88-94. PubMed ID: 22706358
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The clinical effectiveness and cost-effectiveness of primary human papillomavirus cervical screening in England: extended follow-up of the ARTISTIC randomised trial cohort through three screening rounds.
    C Kitchener H; Canfell K; Gilham C; Sargent A; Roberts C; Desai M; Peto J
    Health Technol Assess; 2014 Apr; 18(23):1-196. PubMed ID: 24762804
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Community-based HPV self-collection versus visual inspection with acetic acid in Uganda: a cost-effectiveness analysis of the ASPIRE trial.
    Mezei AK; Pedersen HN; Sy S; Regan C; Mitchell-Foster SM; Byamugisha J; Sekikubo M; Armstrong H; Rawat A; Singer J; Ogilvie GS; Kim JJ; Campos NG
    BMJ Open; 2018 Jun; 8(6):e020484. PubMed ID: 29895648
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost-effectiveness of alternative triage strategies for atypical squamous cells of undetermined significance.
    Kim JJ; Wright TC; Goldie SJ
    JAMA; 2002 May; 287(18):2382-90. PubMed ID: 11988059
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Projected cost-effectiveness of repeat high-risk human papillomavirus testing using self-collected vaginal samples in the Swedish cervical cancer screening program.
    Östensson E; Hellström AC; Hellman K; Gustavsson I; Gyllensten U; Wilander E; Zethraeus N; Andersson S
    Acta Obstet Gynecol Scand; 2013 Jul; 92(7):830-40. PubMed ID: 23530870
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection Rate of High-Grade Cervical Neoplasia and Cost-Effectiveness of High-Risk Human Papillomavirus Genotyping with Reflex Liquid-based Cytology in Cervical Cancer Screening.
    Tay SK; Lin LE; Goh RC
    Ann Acad Med Singap; 2017 Jul; 46(7):267-273. PubMed ID: 28821890
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Perceived Susceptibility to Cervical Cancer among African American Women in the Mississippi Delta: Does Adherence to Screening Matter?
    Gibson EG; Gage JC; Castle PE; Scarinci IC
    Womens Health Issues; 2019; 29(1):38-47. PubMed ID: 30401612
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Participation in Cervical Screening by Self-collection, Pap, or a Choice of Either in Brazil.
    Castle PE; Silva VRS; Consolaro MEL; Kienen N; Bittencourt L; Pelloso SM; Partridge EE; Pierz A; Dartibale CB; Uchimura NS; Scarinci IC
    Cancer Prev Res (Phila); 2019 Mar; 12(3):159-170. PubMed ID: 30651294
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost-effectiveness analysis of the 2019 American Society for Colposcopy and Cervical Pathology Risk-Based Management Consensus Guidelines for the management of abnormal cervical cancer screening tests and cancer precursors.
    Munshi VN; Perkins RB; Sy S; Kim JJ
    Am J Obstet Gynecol; 2022 Feb; 226(2):228.e1-228.e9. PubMed ID: 34547295
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adoption of HPV testing as an adjunct to conventional cytology in cervical cancer screening in Japan.
    Inoue M; Okamura M; Hashimoto S; Tango M; Ukita T
    Int J Gynaecol Obstet; 2010 Nov; 111(2):110-4. PubMed ID: 20708184
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mailed HPV self-sampling for cervical cancer screening among underserved minority women: study protocol for a randomized controlled trial.
    Kobetz E; Seay J; Amofah A; Pierre L; Bispo JB; Trevil D; Gonzalez M; Poitevien M; Koru-Sengul T; Carrasquillo O
    Trials; 2017 Jan; 18(1):19. PubMed ID: 28086983
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-risk HPV testing on self-sampled versus clinician-collected specimens: a review on the clinical accuracy and impact on population attendance in cervical cancer screening.
    Snijders PJ; Verhoef VM; Arbyn M; Ogilvie G; Minozzi S; Banzi R; van Kemenade FJ; Heideman DA; Meijer CJ
    Int J Cancer; 2013 May; 132(10):2223-36. PubMed ID: 22907569
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cost-effectiveness analysis of primary human papillomavirus testing in cervical cancer screening: Results from the HPV FOCAL Trial.
    Cromwell I; Smith LW; van der Hoek K; Hedden L; Coldman AJ; Cook D; Franco EL; Krajden M; Martin R; Lee MH; Stuart G; van Niekerk D; Ogilvie G; Peacock S
    Cancer Med; 2021 May; 10(9):2996-3003. PubMed ID: 33811457
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.